Objective To estimate the procedure‐related risk of miscarriage after amniocentesis and
chorionic villus sampling (CVS) based on a systematic review of the literature and an …

BACKGROUND Chromosomal mosaicism can be detected in different stages of early life: in
cleavage stage embryos, in blastocysts and biopsied cells from blastocysts during …

60 The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) is a
scientific 61 organization that encourages sound clinical practice, and teaching and …

Background Soft markers are nonspecific findings detected by ultrasonography during the
second trimester that are often transient and nonpathologic but may imply an increased risk …

Objective To assess the rate of fetal loss following amniocentesis or chorionic villus
sampling (CVS) in twin pregnancy. Methods MEDLINE, EMBASE and Cochrane databases …

This statement is intended for doctors and staff working in routine, high-risk and specialist
obstetric ultrasound services offering care to pregnant women. Ultrasound investigation is …

Objectives To identify maternal‐, operator‐and procedure‐related variables that affect
procedure‐related pregnancy loss after transcervical (TC) and transabdominal (TA) …

Amniotic fluid is essential for fetus wellbeing and is used to monitor pregnancy and predict
fetal outcomes. Sex affects health and medicine from the beginning of life, but knowledge of …

Sophisticated screening protocols for genetic abnormalities constitute an important
component of current prenatal care, aiming to identify high-risk pregnancies and offer …

Delivering safe clinical trials of novel therapeutics is central to enable pregnant women and
their babies to access medicines for better outcomes. This review describes clinical …